Sunday, 4 October 2026European Markets

FONCIERE INEA And TEXAF Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - fonciere inea (inea.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
fonciere inea (inea.pa) €35.60 7.2% 7.46%
texaf (texf.br) €32.60 4.7% 7.12%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. fonciere inea (inea.pa)

7.2% forward dividend yield and 7.46% return on equity

fonciere inea s.a., a real estate investment company, engages in owning and managing business real estate properties in france. as of december 31, 2010, its property portfolio consisted of 111 buildings. the company was founded in 2005 and is based in paris, france.

earnings per share

as for profitability, fonciere inea has a trailing twelve months eps of €3.84.

pe ratio

fonciere inea has a trailing twelve months price to earnings ratio of 9.27. meaning, the purchaser of the share is investing €9.27 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.46%.

yearly top and bottom value

fonciere inea's stock is valued at €35.60 at 01:30 est, way below its 52-week high of €43.60 and above its 52-week low of €35.10.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, fonciere inea's stock is considered to be overbought (>=80).

more news about fonciere inea.

2. texaf (texf.br)

4.7% forward dividend yield and 7.12% return on equity

texaf s.a. develops, owns, and leases real estate properties in kinshasa. it operates through real estate, digital, and quarries segments. the company's portfolio comprises 332 homes, including 53 villas and 289 apartments with a residential area of 62,200 square meters; 26,300 square meters of office and commercial space; and 30,000 square meters of warehouses, as well as texaf digital campus. it also supplies sandstones for use in concrete production, asphalt for roads, and civil engineering projects. texaf s.a. was founded in 1925 and is headquartered in brussels, belgium. texaf s.a. is a subsidiary of société financière africaine.

earnings per share

as for profitability, texaf has a trailing twelve months eps of €2.01.

pe ratio

texaf has a trailing twelve months price to earnings ratio of 16.22. meaning, the purchaser of the share is investing €16.22 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.12%.

moving average

texaf's worth is below its 50-day moving average of €33.28 and below its 200-day moving average of €34.66.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, texaf's stock is considered to be overbought (>=80).

more news about texaf.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com